2nd Annual Cell & Gene Therapy Pricing & Reimbursement Summit

2nd Annual Cell & Gene Therapy Pricing & Reimbursement Summit is organized by Hanson Wade and will be held from May 27 - 29, 2025 at Washington Marriott Capitol Hill, Washington, Dist of Col, United States of America.

Description;
Recent CGT commercial launches have struggled commercially, hindered by high upfront costs and payer concerns over clinical efficacy and durability. While there remains a pressing need for health system reform, drug developers must adapt their market strategies to ensure commercial success and coverage in the short-term. 

Returning for its 2nd edition, the Cell & Gene Therapy Pricing & Reimbursement Summit is your opportunity to address these barriers. Bringing together leaders from across the healthcare ecosystem, real-world case studies, expert insights, and thought-provoking discussions will shine a light on recent successes and obstacles in achieving sustainable access for CGTs.

Key discussions will explore innovative payment and reimbursement models, the latest developments in risk-sharing agreements, and strategies to secure payer coverage and commercial uptake for approved therapies. You’ll also gainpractical insights into the impacts of the new administration and recent CMSpolicy updates – including the Access Model, Medicaid Drug Rebate Program Final Rule, and proposed changes to inpatient CAR-T reimbursement rates – and their implications for market access strategies.

This event will convene a diverse mix of biopharma companies, payers, government agencies, and market access experts to collaborate on sustainable solutions that improve patient access to these revolutionary therapies.